Frontier Science News
-
Labelscape: A Mobile App for Creating and Printing Specimen Labels
-
OlympiA Phase III trial of Lynparza in the adjuvant treatment of BRCA-mutated HER2-negative high-risk early breast cancer to be analysed and reported early
-
NIH Announces Restructured HIV Clinical Trials Networks
-
IMPAACT 2007 Pharmacokinetic and Safety Data Informs U.S. FDA
-
IMPAACT P1093 Informs U.S. FDA Decision
-
Psychometric Data Linking Using C3PNO Data
-
Buffalo Companies Attacking COVID-19
-
Frontier Science Response to COVID-19: A Message From The CEO
-
Employee Spotlight: Stephen Hart, PhD, Senior Research Scientist
-
NIAID News Release Features IMPAACT P1104s Study Results